McCracken G H, Nelson J D, Thomas M L
Antimicrob Agents Chemother. 1973 Mar;3(3):343-9. doi: 10.1128/AAC.3.3.343.
For infections of the newborn, carbenicillin has theoretical advantages over ampicillin, when given with an aminoglycoside, because of its activity against Pseudomonas and many indole-positive Proteus strains. Agar and broth dilution susceptibility studies demonstrated comparable activities of carbenicillin and ampicillin against coliform organisms but greater resistance of enterococci and Listeria to carbenicillin. However, the significance of the higher inhibitory concentrations is questionable because many serum specimens containing concentrations of carbenicillin lower than the minimal bactericidal values for Listeria and enterococcus strains had demonstrable in vitro bactericidal activity. Carbenicillin and gentamicin combinations had greater antibacterial activities than either drug alone against all enterococci tested and against 50% of Listeria strains. The questions of efficacy raised by contradictory in vitro data may be answered by clinical studies of carbenicillin and gentamicin in infections of the newborn.
对于新生儿感染,羧苄青霉素与氨基糖苷类药物联用时,相较于氨苄青霉素具有理论上的优势,因为它对假单胞菌和许多吲哚阳性变形杆菌菌株具有活性。琼脂稀释法和肉汤稀释法药敏试验表明,羧苄青霉素和氨苄青霉素对大肠菌群的活性相当,但肠球菌和李斯特菌对羧苄青霉素的耐药性更强。然而,较高抑菌浓度的意义值得怀疑,因为许多羧苄青霉素浓度低于李斯特菌和肠球菌菌株最低杀菌值的血清标本在体外具有可证实的杀菌活性。羧苄青霉素和庆大霉素联合使用对所有测试的肠球菌以及50%的李斯特菌菌株的抗菌活性均高于单独使用任一药物。体外数据相互矛盾所引发的疗效问题,可能需要通过羧苄青霉素和庆大霉素用于新生儿感染的临床研究来解答。